ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2017. The put-call ratio across all filers is 3.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,166 | -76.2% | 5,765 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $38,568 | +28.6% | 5,765 | +28.7% | 0.00% | +100.0% |
Q3 2022 | $30,000 | +7.1% | 4,480 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $28,000 | +33.3% | 4,480 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $21,000 | +90.9% | 4,480 | +97.1% | 0.00% | – |
Q4 2021 | $11,000 | -59.3% | 2,273 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $27,000 | -43.8% | 2,273 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $48,000 | -25.0% | 2,273 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $64,000 | +8.5% | 2,273 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $59,000 | -29.8% | 2,273 | 0.0% | 0.00% | -25.0% |
Q3 2020 | $84,000 | -28.2% | 2,273 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $117,000 | +62.5% | 2,273 | 0.0% | 0.01% | +50.0% |
Q1 2020 | $72,000 | -44.2% | 2,273 | +4.9% | 0.00% | -33.3% |
Q4 2019 | $129,000 | +76.7% | 2,166 | +8.7% | 0.01% | +100.0% |
Q3 2019 | $73,000 | -21.5% | 1,993 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $93,000 | +16.2% | 1,993 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $80,000 | -13.0% | 1,993 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $92,000 | +4.5% | 1,993 | 0.0% | 0.01% | +25.0% |
Q3 2018 | $88,000 | +12.8% | 1,993 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $78,000 | -25.7% | 1,993 | +37.9% | 0.00% | -20.0% |
Q1 2018 | $105,000 | +22.1% | 1,445 | +10.3% | 0.01% | +25.0% |
Q4 2017 | $86,000 | +34.4% | 1,310 | 0.0% | 0.00% | +33.3% |
Q3 2017 | $64,000 | +4.9% | 1,310 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $61,000 | +69.4% | 1,310 | +29.3% | 0.00% | +50.0% |
Q1 2017 | $36,000 | – | 1,013 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |